logo

Kura Oncology Inc. (KURA)



Trade KURA now with
  Date
  Headline
9/3/2019 7:41:27 AM Kura Oncology Reports Positive Topline Results From Phase 2 Trial Of Tipifarnib
8/12/2019 4:12:02 PM Kura Oncology Appoints Kathleen Ford As COO
8/2/2019 9:35:11 AM Wedbush Is Raising Kura Oncology Inc. (KURA) FY20 Estimate To -1.54 From -1.68
8/2/2019 9:34:58 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q4 20 Estimate To -0.39 From -0.43
8/2/2019 9:34:48 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q3 20 Estimate To -0.39 From -0.42
8/2/2019 9:34:34 AM Wedbush Is Increasing Kura Oncology Inc. (KURA) Q2 20 Estimate To -0.38 From -0.41
8/2/2019 9:34:28 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q1 20 Estimate To -0.38 From -0.41
8/2/2019 9:34:15 AM Wedbush Is Increasing Kura Oncology Inc. (KURA) FY19 Estimate To -1.49 From -1.58
8/2/2019 9:34:02 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q4 19 Estimate To -0.37 From -0.41
8/2/2019 9:33:51 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q3 19 Estimate To -0.36 From -0.41
7/11/2019 7:37:37 AM Kura Oncology Expands Protection For Tipifarnib With New U.S. And European Patents
6/19/2019 12:06:40 AM Kura Oncology Prices Public Offering Of 5.9 Mln Shares At $17/Shr
3/8/2019 6:22:41 AM Wedbush Is Increasing Kura Oncology Inc. (KURA) FY19 Estimate To -1.80 From -1.94
3/8/2019 6:22:25 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q4 19 Estimate To -0.46 From -0.50
3/8/2019 6:22:18 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q3 19 Estimate To -0.46 From -0.50
3/8/2019 6:22:02 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q2 19 Estimate To -0.45 From -0.48
3/8/2019 6:21:47 AM Wedbush Is Raising Kura Oncology Inc. (KURA) Q1 19 Estimate To -0.44 From -0.47
11/28/2018 7:33:40 AM Kura Oncology Announces New Patent For Tipifarnib In Angioimmunoblastic T-Cell Lymphoma
11/5/2018 4:14:09 PM Kura Oncology Q3 Loss/share $0.40 Vs. Loss $0.38 Year Ago